Recent research has established the detrimental effect of lorazepam, a benzodiazepine, on both implicit and explicit memory. Furthermore, lorazepam is known to affect perceptual integration. Diazepam, on the other hand, though being a benzodiazepine too, only impairs explicit memory, leaving implicit memory fairly intact. Little is known about the effect of diazepam on perceptual integration. The present study aimed at filling in this gap, by comparing the effects of lorazepam and diazepam on the detection of discontinuities in random-shaped outlines. In line with previous findings, the results in a lorazepam-treated group were quite different from the results in a placebo-treated group. The results in a diazepam-treated group were analogous to the results in the placebo-treated group and different from the results in the lorazepam-treated group. This shows that lorazepam and diazepam differ, not only with respect to their effect on implicit memory, but also with respect to their effect on perceptual integration. It is argued that this bears important consequences for memory research that makes use of a pharmacological dissociation rationale.
Introduction
A large amount of research has demonstrated that benzodiazepines can be used to dissociate two forms of memory. At doses with comparable potency, lorazepam impairs both implicit and explicit memory, whereas diazepam impairs only explicit memory, leaving implicit memory fairly intact (for an overview, see Danion, 1994) . In recent years, lorazepam has also proven to be a valuable tool to investigate certain perceptual processes, as it has been shown to impair the integration of contour elements through low-level filling-in (see Giersch, 1999 , for a review). Little is known about the influence of other benzodiazepines, like diazepam, on this perceptual filling-in process.
There is some indirect evidence suggesting that diazepam too would impair filling-in. For one thing, the mechanism underlying this impairment is most probably GABA-mediated and all benzodiazepines are, up until now, believed to interact with the benzodiazepine/ GABA A receptor in fairly the same way (Paul, 1995) . Furthermore, in a study by Sellal et al. (1992) , both lorazepam and diazepam seemed to hamper the identification of newly presented fragmented line drawings, compared to placebo, though the impairment was significant for neither drug (this study, together with a study by Vidailhet et al. (1994) ; see below) was actually the first indication of an influence of benzodiazepines on perceptual integration).
Other evidence suggests that the lorazepam-induced impairment in perceptual integration is not shared by other benzodiazepines, e.g. diazepam. A theoretical argument would be that a GABA-dependent mechanism does not preclude differential effects of various benzodiazepines. For example, the impairment of implicit memory under lorazepam, though not shared by diazepam, seems to be GABA-mediated. Indeed, subsequent administration of a GABA A -antagonist greatly decreases the impairment of implicit memory, as measured using a priming task, following the intake of lorazepam (Bishop & Curran, 1995) . Secondly, in the aforementioned study of Vidailhet et al. (1994) , identification of newly presented fragmented pictures was significantly impaired by lorazepam, but not by diazepam.
To the best of our knowledge, all further research on the influence of benzodiazepines on perceptual integration has been focused on lorazepam; no systematic research has examined the effects of diazepam on perceptual integration. The issue is important though, as impairment of low-level perceptual integration processes could, in some cases, be an alternative account for effects in experimental psychopharmacology that are currently ascribed to a pharmacologically-induced impairment in implicit memory. Our claim is thus, that in order to successfully apply the method of pharmacological dissociation to the study of the role of memory processes in cognitive functioning, one should know the effects of the pharmaca used on other cognitive processes, for instance, perception. This claim holds even more, since most studies examining memory deficits following benzodiazepine administration make use of perceptual priming tasks (Danion, Zimmerman, Willard-Schroeder, Grangé, & Singer, 1989; Legrand et al. 1995; Sellal et al., 1992; Vidailhet et al., 1994; Vidailhet, Kazès, Danion, Kauffmann-Muller, & Grangé, 1996) or other perceptual tasks (Wagemans, Notebaert, & Boucart, 1998) to evaluate implicit memory functioning. An impairment in visual functioning might thus lead to poor performance on such a task, even if memory functioning is intact. Therefore, in order to be able to use such tasks for the evaluation of benzodiazepine influences on memory functioning, it is extremely important to decide on the issue of whether or not diazepam induces an impairment in perceptual integration, as does lorazepam.
The present study was designed to shed some light on this issue. To this end, we adapted a design previously used by Lamote and Wagemans (1999) . In their study, meaningless smoothly curved outlines were briefly presented, immediately followed by a masking stimulus. Half of the outlines were shown with full contour, the other half contained contour deletions (41 pixels removed) at three inflections (points of transition between contour convexity and contour concavity, where curvature is zero), at three loci of large contour convexity (where curvature is at a local positive maximum) or at three loci of large contour concavity (where curvature is at a local negative minimum). Participants were simply asked to judge whether or not the outlines shown had a fully closed contour. The results showed that deletions around inflections and deletions around negative minima were difficult to detect, relative to the detection of deletions around positive maxima. The rather poor detection of deletions around negative minima may be attributed to the fact that such gaps induce a segmentation of the contour in its natural parts (Hoffman & Richards, 1984) . For the relatively poor detection of inflection gaps, automatic filling-in may be held responsible: Boundary completion through filling-in occurs due to interpolation between collinear line-segments (Kellman & Shipley, 1991; Kovács & Julesz, 1993 ; for a more general overview of perceptual filling-in phenomena, see Pessoa, Thompson, & Noë, 1998) and is, as such, much more pronounced at inflection gaps than at minima or maxima gaps (compare Fig. 1(d) with Fig.  1(b,c) ). We adapted the experiment and ran it under pharmacological conditions (lorazepam, diazepam, placebo) . We predicted that the pattern of results for the placebo group would mirror the pattern found by Lamote and Wagemans (1999) , i.e. deletions at inflections and deletions at negative minima harder to detect than deletions at positive maxima. For the lorazepam group, a relatively better detection of inflection deletions compared to the placebo group was expected, due to a disruption of perceptual filling-in. The crucial comparison would be the comparison between the pattern of results for the diazepam group and the pattern of results for the other two groups. If the pattern of results for the diazepam group mirrored the pattern for the lorazepam group, then this would indicate that diazepam disrupts filling-in, much the same way as lorazepam. If the pattern of results for the diazepam group was similar to the pattern for the placebo group, then this would point to the disruption of perceptual filling-in being specific for lorazepam (or a yet to be defined subgroup of benzodiazepines). 
Material and methods

Subjects
The study was approved by the 'Comité Consultatif de Protection des Personnes dans la Recherche Bioméd-icale d'Alsace I -Strasbourg'. Thirty paid (1000 FF) healthy volunteers of both sexes (12 male, 18 female), 18 -35 years of age, were recruited from the Faculty of Medicine at the University of Strasbourg. They had no medical illness or history of alcoholism, drug abuse or tobacco consumption of more than ten cigarettes per day. They were no chronic users of benzodiazepines and none had taken any concomitant medication for at least 21 days. Subjects were instructed to abstain from beverages containing caffeine or alcohol for the 24 h prior to the study. All subjects were tested in the morning after an overnight fast. They all had normal or corrected-to-normal vision. Written informed consent was obtained from all volunteers before they entered the study.
Stimuli
Stimuli were adapted from the set of smoothly curved outlines of Lamote and Wagemans (1999) . The original set was created using a program that, according to the method of Akima (1970) , generates the curves based on a few self-chosen dots. The software also calculates curvature in each point on the contour and indicates curvature singularities (negative minima, positive maxima and inflections). Stimuli had to meet certain criteria: reasonable amount of contour variation, balanced distribution of positive and negative curvature and reasonable distance between curvature singularities. Forty stimuli were created meeting these criteria. Twelve versions of all stimuli were created: four minima-deleted, four maxima-deleted and four inflection-deleted versions. To this end, 41, 31, 21 or 11 pixels were removed around each of three curvature singularities. For the maxima and the minima versions, the three points with the highest absolute curvature were removed, together with 20, 15, 10 or 5 points to the left and to the right. For the inflection versions, the three inflections for which the lowest absolute curvature of the two neighboring extrema was maximal, together with the surrounding pixels, were removed (see Fig. 1 ).
Experimental procedure and drugs
Subjects were randomly assigned to one of three parallel groups of ten subjects each: a placebo (lactose 190 mg) group, a lorazepam 0.038 mg/kg group and a diazepam 0.3 mg/kg group. Because our main interest was in the effect of both drugs on perceptual integration at those doses ordinarily used to pharmacologically dissociate implicit and explicit memory, drug doses were chosen accordingly. At these doses, both drugs can furthermore be considered to be equally potent, as evidenced by the equivalence of their effects on sedation and on explicit memory (Dundee, McGowan, Lilburn, McKay, & Hegarty, 1979; Kothary, Brown, Pandit, Samra, & Pandit, 1981; Sellal et al., 1992; Vidailhet et al., 1994) . Drugs were administered orally using a double-blind procedure. In order to evaluate the effects of each drug at its peak plasma concentration, which is usually attained within 60 min after oral administration for diazepam and within 120 min for lorazepam (Greenblatt, Scavone, Harmatz, Engelhardt, & Shader, 1993; Mandelli, Tognoni, & Garattini, 1978) , a double-placebo procedure was used. Subjects in the diazepam group received placebo at 07:30 h and diazepam at 08:30 h; subjects in the lorazepam group received lorazepam at 07:30 h and placebo at 08:30 h; subjects in the placebo group received placebo at both times.
The day before the actual experiment would take place, subjects performed training sessions in order to individually adapt the overall level of difficulty of the task. The individual adaptation was implemented to ensure a moderate performance level for all subjects, as significant detection differences (measured using d%s) between the various deletion conditions can only be found if the task is neither too easy nor too difficult overall. This manipulation, necessary as it was, limits the inferences that can be validly made from the results; we will elaborate on this in the discussion. On the test day, the training was repeated before starting the actual experiment, as the benzodiazepines could provoke sedation that would lower overall performance. Two subjects were tested per day, the first starting at 09:00 h, the second starting at 10:20 h; the experiment was part of a series of experiments on visual perception and visual attention.
Experimental design
Training sessions consisted of 78 trials presented in random order. Each of 39 stimuli was presented once in its non-deleted version and once in one of three possible deleted versions (13 in minima-deleted, 13 in maxima-deleted and 13 in inflection-deleted version).
1 Each trial started with a fixation point that was presented at screen centre for 500 ms. After a 250 ms interval, the target stimulus was presented for a multiple of 17.7 ms. The target was immediately followed by a masking stimulus (consisting of 200 circles with random position and radius) that stayed on screen for 250 ms. Subjects were simply asked to indicate whether they thought the presented outline to be continuous or not, by pressing the zero key (discontinuous contour) or the space bar (continuous contour). Fixation point, target and mask were presented as white stimuli on a black background. At the end of each session, feedback was provided in the form of an overall percentage of correct responses. This feedback was used to adapt the difficulty of the task. Task difficulty could be adapted by adjusting the gap size (41, 31, 21, or 11 pixels per gap) or the presentation time of the stimuli (a multiple of 17.7 ms). Training started with a 41 pixels/53 ms session and continued until overall performance approached 75% of correct responses (with 50% being chance level and 100% being perfect performance).
The actual experiment consisted of six blocks of 80 trials each. Each block included the continuous versions of the 40 stimuli and the deleted versions of one condition (two blocks with the negative minima deletions, two blocks with the positive maxima deletions, two blocks with the inflection deletions); the blocks were presented in random order, with the restriction that all conditions had to have passed once before a condition was presented for the second time. There was a self-terminated pause after each block. The course of the trials was the same as in the training sessions; the order of the trials was randomized within each block. Gap size and presentation duration were set individually, based on the performance during training, as to approach an overall performance of 75% correct responses.
Apparatus
The experiment was run on an IBM-compatible Fuji Tech 66 MHz 486 DX2 PC with an SVGA graphics card, connected to a Sony Trinitron 14¦ screen. With a resolution of 800× 600 pixels, the refresh rate was 56.6 Hz. The experiment, as well as the training sessions, were performed monocularly with the dominant eye, as benzodiazepines are known to disrupt binocular vision (Giersch, Boucart, Speeg-Schatz, Kauffmann-Muller & Danion, 1996) . Viewing distance was 100 cm; stimuli measured :5°of visual angle. Testing was performed in a dimly lit room.
Analysis
Signal detection measures (d%s) were calculated for each experimental block. These d%s are defined as the z-value of the proportion of hits minus the z-value of the proportion of false alarms (Macmillan & Creelman, 1991) . For each experimental group (placebo, lorazepam, diazepam), the d%s were subjected to an analysis of variance (ANOVA), with gap condition (negative minima, positive maxima or inflections) and repetition condition (first or second presentation) as within-subjects variables (the experiment can be conceived of as consisting of two halves with in each half one blocked presentation of each gap condition; see Section 2.4). The level of significance was set at hB 0.05.
Results
Six subjects were excluded from the analysis because their overall performance deviated too much from the norm of 75% of correct responses. These subjects had a proportion of correct responses below 0.65 (n= 4) or above 0.85 (n= 2). Of the remaining subjects, nine were in the placebo group, six were in the diazepam group and nine were in the lorazepam group. Mean proportion of correct responses was 0.74 (same proportion with all subjects included).
For the placebo group, the 3×2 ANOVA on the d%s revealed no significant main effects nor a significant interaction. Most importantly, gaps were equally detectable in all three gap conditions (inflections: d%= 2.11; maxima: d% =1.99; minima: d% = 2.07; see Fig. 2 ).
For the lorazepam group, there was a marginally significant effect of gap condition, F(2,16)= 3.53, P: 0.054. A least significant differences (LSD) test revealed that gaps at inflections (d% = 2.10) were significantly better detected than maxima gaps (d%= 1.50), while detection of minima gaps (d%= 1.74) did not differ significantly from detection of both inflection and maxima gaps (see Fig. 2) . The difference between detection of gaps at inflections and gaps at maxima remained significant when a more conservative Tukey honest significant differences (HSD) test was applied instead of an LSD test. All other effects were non-significant.
For the diazepam group, the pattern of results was highly parallel to the pattern of results for the placebo group (see Fig. 2 ). No significant effects were found; gaps were equally detectable at inflections (d%= 1.74), maxima (d%= 1.62) and minima (d%= 1.68).
As the repetition factor did not have a significant effect for any of the three groups, the average d%s have been collapsed over both experimental halves in Fig. 2 .
Apart from the sensitivity measure (d%), average reaction times were calculated for each participant. Only trials in which a correct response was given were included (74% of the data). Overall, there was a significant negative correlation between this measure and a d% calculated over all blocks (r(24) = −0.44, P B0.05). Thus, the longer the average reaction time of a given subject, the worse his global signal detection. ANOVAs per group revealed no significant differences in mean reaction time between gap conditions. Finally, visual-analogue scales were used to assess subjective sedation of the subjects (Bond & Lader, 1974) . The scales were rated by the subjects, the first time prior to drug administration (base-line rating) and the second time at 09:35 or 10:55 h (depending on the hour of beginning of testing). From the ratings at each moment a sedation score was calculated, after which the base-line score was subtracted from the second score. This difference score (DS) was then used as an index of subjective sedation and subjected to an ANOVA with pharmacological condition as betweensubjects variable. The main effect of pharmacological group was non-significant. An LSD test revealed a marginally significant difference in subjective sedation between placebo group (DS= 11.11) on the one hand and lorazepam group (DS= 24.20) and diazepam group (DS= 27.07) on the other hand (P : 0.085 and 0.062, respectively). The correlation between subjective sedation and global signal detection (d%) was non-significant nor was the correlation between subjective sedation and average reaction time.
Discussion
The results of the experiment can be summarized as follows. In the placebo group, there are no differences in detection of gaps at inflections, at positive maxima or at negative minima. In the lorazepam group, detection of gaps at inflections is better than detection of gaps at positive maxima; detection of gaps at negative minima does not differ from detection of gaps in both other conditions. In the diazepam group, the pattern of results is as in the placebo group. Longer overall average reaction times go together with lower overall signal detection. Subjective sedation tends to be higher in the lorazepam and in the diazepam group compared to the placebo group, though not significantly so. There is no significant correlation between overall signal detection and subjective sedation nor between overall average reaction time and subjective sedation.
Before we go on to interpret these findings, we should warn against another way of looking at the data, that, tempting as it may be, is invalid. Looking at Fig. 2 , one might indeed be inclined to make direct comparisons between the data of the various drug groups. Such comparisons are by no means allowed. As outlined in Section 2, the overall level of difficulty of the experimental task was adjusted for each subject by adapting gap width and presentation duration, to ensure that global performance of each participant (over all gap conditions) was largely above chance level, but far from perfect. Only in this way, a priori chances for the appearance of significant gap detection differences between gap conditions could be considered to be equal for the three drug groups. As a consequence though, the results for the three gap conditions are not independent within each group: Better performance in one gap condition has to go at the cost of performance in one or both of the other gap conditions. Furthermore, and most importantly, the individual manipulation of the objective task difficulty implies that differences between the three drug groups in global performance are irrelevant and may by no means be interpreted, as they are confounded by the manipulation of the global performance level of each individual participant. As a result, only the pattern of results within each drug group may be compared between drug groups.
The absence of an effect of gap condition in the placebo group is as surprising as it is puzzling. Indeed, a better detection of maxima gaps compared to the other two conditions was expected. Not only are the present results hard to reconcile with the results of Lamote and Wagemans (1999) , they are also not in line with the results of a pilot study (n= 7) that we did with the same paradigm in which gaps at maxima were significantly better detected than gaps at minima (d%= 2.02 and d%= 1.60, respectively, unpublished data). Any explanation must remain speculative. It is a fact that, in general, smaller gaps and shorter stimulus presentations were needed in the present experiment compared to the Lamote and Wagemans (1999) experiment in order to obtain comparable overall percentages of correct responses. This suggests at least that the task was not completely the same for our subjects as it was for the subjects of Lamote and Wagemans (1999) . But, it remains unclear what the crucial distinctions were between the present experiment and the previous ones on a procedural level. One might have been the addition of a training phase, in which the various gap conditions were presented intermixed instead of blocked, as in the actual experimental phase. Another difference was, of course, the individual adaptation to the difficulty of the experimental task in order to guarantee an intermediate level of correct responses.
Whatever the reason may be, it does not affect interpretation of the results for the other two groups. Indeed, as the experimental circumstances were completely identical for these groups and the placebo group, the results for these groups can be interpreted in comparison with the results of the placebo group.
Compared to the pattern of results for the placebo group, the results for the lorazepam group are in line with our expectations. Inflection gaps are indeed relatively easier to detect than in the placebo group, largely at the cost of detection of maxima gaps. As explained in Section 1, this result fits in with the disruption of perceptual integration processes under the influence of lorazepam, a disruption that should affect mainly filling-in of straight contour gaps, such as gaps at inflections.
2 As such, this result corroborates earlier findings in an entirely different paradigm.
More novel is the pattern of results in the diazepam group. This pattern is identical to the pattern of results for the placebo group and unlike the pattern of results for the lorazepam group. In contrast with the lorazepam group, gaps at inflections were no easier to detect than gaps at other curvature singularities in the diazepam group.
As such, our results can be taken as first evidence that lorazepam and diazepam differ not only with respect to their effect on implicit memory functioning, but also with respect to their effect on perceptual integration. The conclusion of the present study is that, at the doses used, diazepam does not impair perceptual integration, whereas lorazepam does. If the selective influence of lorazepam on perceptual integration is further corroborated, this bears important implications for future pharmacological dissociation research involving benzodiazepines, because the doses used in the present study were chosen in accordance with the doses ordinarily used in pharmacological memory research. When using lorazepam and diazepam to evaluate the contribution of implicit memory processes on cognitive functioning, impairment of perceptual integration may thus always be an alternative account for possible differences between lorazepam-and diazepam-treated subjects. Differentiating between both accounts (the 'perceptual' account versus the 'memory' account) is not always obvious, and should be considered beforehand.
The question why lorazepam and diazepam should have different effects on perceptual integration remains to be settled, as both drugs are supposed to enhance GABA A -mediated inhibition to a comparable extent. However, recent evidence suggests that both drugs have a different impact on the frequency characteristics of GABA A -mediated neuronal activity. Lorazepam seems to enhance neuronal synchronization, whereas diazepam does not and this neuronal synchronization is supposed to play an important role in the emergence of perceptual grouping (Elliott, Becker, Boucart, & Mü ller, 2000) . This is the only other study that we are aware of that has shown lorazepam and diazepam to have different effects on perceptual organization. It remains to be seen to what extent differences in neuronal synchronization can also be held responsible for differential influences of lorazepam and diazepam on low-level perceptual integration. Furthermore, the molecular mechanisms underlying this neuronal synchronization can only be speculated upon. More research on the effects of benzodiazepines on neural functioning will thus be needed in order to yield insight in how and where perceptual integration is occurring. However, the present research does suggest that a particularly fruitful strategy might be to look for neuronal effects that are not common to all benzodiazepines, but are specific to lorazepam or a yet to be defined subgroup of benzodiazepines (not including diazepam).
2 It should be noted that the absolute distance between line-ends was somewhat larger for inflection gaps than for maxima and minima gaps, due to the equal number of pixels removed. One might be tempted to propose that this would actually make inflection gaps easier to detect than the two other types of gaps. The difference in absolute distance was rather small though. Furthermore, the process of filling-in that prevents gap detection is, within certain limits, more dependent on the collinearity of the line-ends involved than on the distance between them (Kellman & Shipley, 1991; Kovács & Julesz, 1993; Lamote & Wagemans, 1999) . Therefore, it is safe to suppose that in the present experiment, a disruption of perceptual integration processes would affect inflection gaps more than gaps at maxima or at minima. This assumption is supported by further analyses that showed that, with increasing number of pixels removed (11, 21, 31 or 41), detection of inflection gaps did not become better relative to both other types of gaps, even though the difference in absolute distance between line-ends can be supposed to increase with increasing number of pixels removed.
